Walgreens Boots Alliance Inc.
WBABusiness Overview
ticker: WBA step: 01 generated: 2026-05-12 source: quick-research
Walgreens Boots Alliance, Inc. (WBA) — Business Overview
⚠️ STATUS: NO LONGER PUBLICLY TRADED
Sycamore Partners completed acquisition August 28, 2025. WBA delisted from NASDAQ. Operates as private company split into 5 standalone businesses: Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD.
Business Description (pre-take-private)
Walgreens Boots Alliance was one of the world's largest retail pharmacy chains and the first global pharmacy-led, health and wellbeing enterprise. WBA operated ~12,500 stores across the US (Walgreens) + Europe + Asia (Boots, Benavides, Ahumada) before take-private. Filed major restructuring under CEO Tim Wentworth (Nov 2023) including 1,200+ store closures + VillageMD divestiture.
Revenue Model (pre-take-private)
~$150B FY2024 (fiscal year ending Aug 2024) revenue across three segments: U.S. Retail Pharmacy (~80%, prescriptions + front-store retail), International (~15%, Boots UK + others), U.S. Healthcare (~5%, VillageMD primary care, Shields, CareCentrix). PBM-reimbursed prescription revenue dominant. Front-store retail (cosmetics, beauty, food, OTC) increasingly pressured.
Products & Services (pre-take-private)
- Walgreens US retail pharmacy — ~8,000 stores; prescription + OTC + beauty + photo
- Boots UK + International — ~2,000 stores Boots UK + Benavides Mexico + Ahumada Chile
- VillageMD — Primary care clinics co-located in Walgreens (divested in process)
- Shields Health Solutions — Specialty pharmacy services (divested in process)
- CareCentrix — Post-acute home health (divested in process)
- Owned brands — Boots No.7, Soap & Glory, Liz Earle (Boots UK)
Customer Base & Go-to-Market (pre-take-private)
~110M Walgreens app users; ~70M MyWalgreens members. Front-store consumer shopper increasingly losing to Amazon + dollar stores + mass retail (Target, Walmart). Pharmacy customers: ~80%+ insured (PBM-reimbursed). 24M Boots Advantage Card members in UK.
Sycamore Partners Take-Private Deal Structure
- Total transaction value: up to $23.7B
- Shareholders received: $11.45/share cash + 1 non-transferable right (up to $3.00 from VillageMD monetization)
- Closed: August 28, 2025
- Stefano Pessina (largest shareholder): 100% reinvest interests
- Post-deal structure: 5 standalone private companies
Key Facts
- Founded: 1901 (Walgreens); 2014 (WBA merger Walgreens + Alliance Boots)
- Headquarters: Deerfield, IL (pre-deal)
- Employees: ~330,000 (pre-deal)
- Exchange: NASDAQ (WBA — delisted August 28, 2025)
- Sector / Industry: Consumer Staples / Drug Retail
- Status: PRIVATE (no longer publicly traded)
Financial Snapshot
ticker: WBA step: 04 generated: 2026-05-12 source: quick-research
Walgreens Boots Alliance (WBA) — Financial Snapshot
⚠️ STATUS: NO LONGER PUBLICLY TRADED
WBA delisted from NASDAQ August 28, 2025 following Sycamore Partners $23.7B take-private acquisition.
Income Statement Summary (pre-take-private)
| Metric | FY2022 | FY2023 | FY2024 | FY2025E |
|---|---|---|---|---|
| Revenue | $132.7B | $139.1B | $147.7B | $150.4B |
| U.S. Retail Pharmacy Comp Sales | – | -1% | -1.7% | -4% to -5% |
| Net Income (GAAP) | $4.34B | -$3.08B | -$8.6B | – |
| Adjusted EPS | $5.04 | $3.98 | $2.88 | $1.40-1.80 (guide) |
Fiscal year ends August. FY24 GAAP -$8.6B reflects $12B goodwill impairment + VillageMD charges. Adj EPS deteriorating from $5+ peak to $1.40-1.80 guide for FY25.
Cash Flow & Balance Sheet (pre-take-private, FY2024)
| Metric | Value |
|---|---|
| Operating Cash Flow | ~$1.0B (vs ~$2.3B FY23) |
| Free Cash Flow | ~$0.4B |
| Cash & Equivalents | ~$0.7B |
| Total Debt | ~$12B+ |
| Net Debt/EBITDA | Elevated |
Final Take-Private Terms (Aug 28, 2025)
- Sycamore Partners acquired WBA for $11.45/share + up to $3.00 contingent value right
- Total transaction value: up to $23.7B (including debt)
- VillageMD CVR backed by future divestiture proceeds (estimated ~$2.7B total)
Sycamore's Operating Plan (2026+)
- Aggressive surgical removal of unprofitable assets
- Already closed >500 of 1,200 targeted stores by early 2026
- Massive corporate layoffs
- Five separate operating companies
- No public financial reporting going forward
Deeper Financial Analysis
The fundamental tier adds 9 additional research dimensions for $WBA.